Shock Wave Therapy Plus Exercise in GTPS

Shock Wave Therapy Combined With Strengthening Exercise of Hip Abductor Muscles in the Greater Trochanteric Pain Syndrome: a Randomized Controlled Trial

Status

Active, not recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06248905

Acronym

GTPSSWEX

Enrollment

Registered

2024-02-08

Start date

2024-01-26

Completion date

2027-02-01

Last updated

2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Greater Trochanteric Pain Syndrome of Both Lower Limbs

Brief summary

The aim of this randomized controlled study is to investigate if the sequential administration of focused shock wave therapy and of a rehabilitation program based on the strengthening of gluteal muscles is more effective than a standard shock wave treatment for greater trochanteric pain syndrome

Interventions

OTHERRehabilitation program based on the strengthening of gluteal muscles

Physiotherapy program (8 weeks)

OTHERExtracorporeal shock wave therapy

Focused shock wave therapy (3 weeks)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Unilateral hip pain of four weeks or longer duration * Pain to palpation in the greater trochanteric area at physical examination * Pain in hip end-range abduction/rotation/adduction at physical examination * Gluteal tendinopathy, in absence of full thickness tears at a sonographic examination of the gluteal tendons * Adult age and written informed consent

Exclusion criteria

* No hip osteoarthritis, diagnosed according to Altman's criteria * No history of knee osteoarthritis * No history of rheumatologic diseases * No previous fractures or surgery in the affected limb * No clinical signs of lumbar radiculopathy at physical examination * No corticosteroid injections, since the onset of the current pain episode * No general contraindication to shock wave therapy (pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area)

Design outcomes

Primary

Measure	Time frame	Description
NRS Pain	6 months	Change in lateral hip pain measured by the Numeric Rating Scale (NRS)

Secondary

Measure	Time frame	Description
EQ5D Quality of life	12 months	Change in quality of life measured by EQ-5D-3L
VISA-G Disability	12 months	Change in disability measured by VISA-G questionnaire
Functional capacity (strength of gluteal muscles)	12 months	Change in functional capacity measured by MRC scale

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026